Targeting KRASG12V Mutations with HLA Class II-restricted TCR for the Immunotherapy in Solid Tumors
FRONTIERS IN IMMUNOLOGY（2023）
关键词
KRAS G12V mutation,T cell receptor-engineered-T cell,immunotherapy,human leukocyte antigen-DPB*0301,human leukocyte antigen-DPB*1401,solid tumor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要